News, Updates & Media Briefs
KAPI Leadership Pays a Courtesy visit to the PS, Ministry of Health
On Tuesday 26th January 2021 the Kenya Association of Pharmaceutical Industry (KAPI) executive board led by the Chairperson, Willy Soriney paid a courtesy visit to the
Biopharmaceutical Companies Take Lead in COVID-19 Response in Kenya
As a membership organization driven by tenets of social responsibility and commitment to public health, in the wake of COVID-19 it is in our purview
Aspirin abuse likely to cause brain damage
Health experts have warned against arbitrary use of aspirin in managing high blood pressure. Responding to an emailed inquiry by this writer, Dr Loise Nyanjau
Big pharma’s healthy contribution
With a macroeconomic growth of between five and 10 per cent, according to the 2016-2017 Comesa biennial report, Kenya was recognised as one of the
KAPI confirms commitment to affordably deliver Non-Communicable Diseases medicines
The Kenya Association of Pharmaceutical Industry (KAPI) has expressed its commitment to continue facilitating a progressive reduction in the cost of Non communicable diseases (NCDs)
KENYA FEATURES PROMINENTLY IN GLOBAL PHARMACEUTICAL INDUSTRY REPORT
…As the global pharmaceutical industry advocates for even greater collaboration as critical to future global health progress The International Federation of Pharmaceutical Manufacturers & Associations